# Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma

> **NCT05654896** · PHASE3 · UNKNOWN · sponsor: **Nadeem Iqbal** · enrollment: 158 (estimated)

## Conditions studied

- Antibiotic Prophylaxis

## Interventions

- **DRUG:** Ceftriaxone Sodium

## Key facts

- **NCT ID:** NCT05654896
- **Lead sponsor:** Nadeem Iqbal
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-26
- **Primary completion:** 2023-11-26
- **Final completion:** 2023-12-26
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2022-12-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05654896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05654896, "Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05654896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*